Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
An acute, short-lived, viral disease of infants and young children characterized by a high fever at onset that drops to normal after 3-4 days and the concomitant appearance of a macular or maculopapular rash that appears first on the trunk and then spreads to other areas. It is the sixth of the classical exanthematous diseases and is caused by HHV-6; (HERPESVIRUS 6, HUMAN). (From Dorland, 27th ed)
A calicivirus infection of swine characterized by hydropic degeneration of the oral and cutaneous epithelia.
The type species of the genus VESIVIRUS infecting pigs. The resulting infection is an acute febrile disease which is clinically indistinguishable from FOOT AND MOUTH DISEASE. Transmission is by contaminated food.
The suborder of aquatic CARNIVORA comprising the WALRUSES; FUR SEALS; SEA LIONS; and EARLESS SEALS. They have fusiform bodies with very short tails and are found on all sea coasts. The offspring are born on land.
The type species of ROSEOLOVIRUS isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter NK cell activity. HHV-6; (HBLV) antibodies are elevated in patients with AIDS, Sjogren's syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. HHV-6 is the cause of EXANTHEMA SUBITUM and has been implicated in encephalitis.
A family of RNA viruses infecting a broad range of animals. Most individual species are restricted to their natural hosts. They possess a characteristic six-pointed starlike shape whose surfaces have cup-shaped (chalice) indentions. Transmission is by contaminated food, water, fomites, and occasionally aerosolization of secretions. Genera include LAGOVIRUS; NORWALK-LIKE VIRUSES; SAPPORO-LIKE VIRUSES; and VESIVIRUS.
A species of VARICELLOVIRUS causing coital exanthema in horses.
Species of ENTEROVIRUS causing mild to severe neurological diseases among pigs especially in Eastern Europe. Mild strains are also present in Canada, U.S., and Australia. Specific species include Porcine enterovirus A and Porcine enterovirus B.
A group comprised of several species of aquatic carnivores in different genera, in the family Otariidae. In comparison to FUR SEALS, they have shorter, less dense hair.
Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
A species in the genus ROSEOLOVIRUS, of the family HERPESVIRIDAE. It was isolated from activated, CD4-positive T-lymphocytes taken from the blood of a healthy human.
Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.
A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic.
A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.
A fleshy extension at the back of the soft palate that hangs above the opening of the throat.
Quinolizines are heterocyclic organic compounds containing a bicyclic structure formed by a benzene ring fused to a piperidine ring, which have been used as building blocks in the synthesis of various pharmaceuticals and bioactive molecules.
Infection with ROSEOLOVIRUS, the most common in humans being EXANTHEMA SUBITUM, a benign disease of infants and young children.
A family of phylloquinones that contains a ring of 2-methyl-1,4-naphthoquinone and an isoprenoid side chain. Members of this group of vitamin K 1 have only one double bond on the proximal isoprene unit. Rich sources of vitamin K 1 include green plants, algae, and photosynthetic bacteria. Vitamin K1 has antihemorrhagic and prothrombogenic activity.
Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
Virus diseases caused by the HERPESVIRIDAE.
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications.
A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985, p133), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed).
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.
A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties.
Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).
Substances that reduce the growth or reproduction of BACTERIA.

A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq (nolatrexed dihydrochloride) given by 10-day oral administration. (1/437)

2-Amino-3,4-dihydro-6-methyl-4-oxo-5-(4-pyridylthio)-quinazoline dihydrochloride (nolatrexed dihydrochloride, Thymitaq, AG337), a specific inhibitor of thymidylate synthase, was developed using protein structure-based drug design. Intravenously administered nolatrexed is active clinically. As oral bioavailability is high (70-100%), nolatrexed was administered orally, 6 hourly for 10 days, at 3-week intervals, and dose escalated from 80 to 572 mg m(-2) day(-1) in 23 patients. Common toxicity criteria (CTC) grade 3 toxicities included nausea, vomiting, stomatitis and liver function test (LFT) abnormalities. Thrombocytopenia (grade 1 or 2) occurred at doses > or = 318 mg m(-2) day(-1) and neutropenia (grade 2) at 429 and 572 mg m(-2) day(-1). An erythematous maculopapular rash occurred at dosages > or = 318 mg m(-2) day(-1) (7 out of 19 patients). LFT abnormalities occurred in two out of six patients (grade 3 or 4 bilirubin and grade 3 alanine transaminase) at 572 mg m(-2) day(-1). Nolatrexed plasma concentrations 1 h after dosing were 6-16 microg ml(-1), and trough 3-8 microg ml(-1), at 572 mg m(-2) day(-1). Inhibition of thymidylate synthase was demonstrated by elevation of plasma deoxyuridine. Six-hourly oral nolatrexed for 10 days was associated with antiproliferative effects, but nausea and vomiting was dose limiting at 572 mg m(-2) day(-1). Nine patients were treated at 429 mg m(-2) day(-1); three out of nine experienced grade 3 nausea, but 17 out of 22 treatment courses were completed (with the co-administration of prophylactic antiemetics) and this dose level could be considered for phase II testing.  (+info)

The pharmacokinetics and safety profile of oral ganciclovir in combination with trimethoprim in HIV- and CMV-seropositive patients. (2/437)

AIMS: We investigated the pharmacokinetics and safety profile of oral ganciclovir coadministered with trimethoprim in HIV-and CMV-seropositive patients. METHODS: In an open-label, randomized, 3-way crossover study, 12 adult males received oral ganciclovir 1000 mg every 8h, oral trimethoprim 200 mg once daily, or both drugs concomitantly in a sequence of three 7-day treatment periods. Pharmacokinetic parameters were determined and adverse events recorded for each treatment. RESULTS: The presence of trimethoprim significantly decreased CLr (12.9%, P=0.0068) and increased t1/2 (18.1%, P=0.0378) of ganciclovir. However, these changes are unlikely to be clinically meaningful. There were no statistically significant changes in trimethoprim pharmacokinetic parameters in the presence of ganciclovir, with the exception of a 12.7% increase in Cmin. Ganciclovir was well tolerated when administered alone or in combination with trimethoprin. CONCLUSIONS: There was no clinically significant pharmacokinetic interaction between oral ganciclovir and trimethoprim when coadministered.  (+info)

Extralymphatic disease due to bancroftian filariasis. (3/437)

Infection with Wuchereria bancrofti, Brugia malayi, or B. timori not only affects the structure and function of lymphatic vessels but is also associated with extralymphatic pathology and disease. Because it is now possible to detect living adult worms by ultrasonography, much emphasis is placed on lymphatic pathology. However, the finding of renal damage in asymptomatic microfilaremic carriers has led to increased recognition of the importance of extralymphatic clinical manifestation in bancroftian filariasis. The authors present a number of clinical syndromes that may be manifestations of extralymphatic filarial disease and discuss possible mechanisms that cause these conditions. The main purpose of this paper is to raise the awareness of students and physicians of the prevalence and the importance of extralymphatic disease in bancroftian filariasis so that it is diagnosed and treated properly and also to alert for the need of additional research in this area.  (+info)

Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian Nurse Bone Marrow Transplant Group (GITMO). (4/437)

BACKGROUND AND OBJECTIVE: Care of central venous catheter (CVC) in patients undergoing bone marrow transplantation (BMT) raises significant problems related to the high risk of local infections due to the immunodeficient status, which in itself is a predisposing factor for systemic blood-stream infections. Although frequent changes of CVC dressing might theoretically reduce the incidence of infections, they are also accompanied by significant skin toxicity and patient discomfort. No study has yet addressed these points. The objective of this study was to compare two different time interval protocols for CVC dressing in order to assess the effects on local infections and toxicity. DESIGN AND METHODS: In a multicenter study, 399 bone marrow transplant (BMT) patients with a tunneled CVC (Group A, 230 pts) or a non-tunneled one (Group B, 169 pts) were randomly allocated to receive CVC dressing changes every 5 or 10 days, if belonging to Group A, or 2 or 5 days, if in Group B. Transparent, impermeable polyurethane dressings were used for all patients. The rate of local infections at the site of CVC insertion was assessed by microbiological assays every 10 days, while the severity of skin toxicity was measured according to the ECOG scale. RESULTS: Sixty-five per cent of enrolled patients were finally evaluable. Patients (in both Groups) receiving CVC dressing changes at longer intervals did not show a significant increase in the rate of local infections, while those who received dressing every 2 days had a significant increase in local skin toxicity. Longer intervals were accompanied by a reduction in costs. INTERPRETATION AND CONCLUSIONS: The results of this study demonstrate that the increase in time interval between CVC dressing changes in BMT patients did not raise the risk of local infections, while significantly reducing patient discomfort and costs.  (+info)

The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer. (5/437)

The evaluation of new therapies in prostate cancer requires unique end points for agents with diverse mechanisms of action. Because retinoic acid may have a confounding effect on prostate-specific antigen, we incorporated a pathological end point into the outcome assessment of two sequential clinical trials using all-trans-retinoic acid (ATRA) and the combination of 13-cis-retinoic acid and IFN-2a (cRA inverted question markIFN). Pre- and posttherapy tumor biopsy specimens were studied for histological changes, apoptosis (terminal deoxynucleotidyl transferase-mediated nick end labeling assay), and proliferation index (Ki67). Prostate-specific membrane antigen (PSMA) expression was also evaluated using two different monoclonal antibodies to its intracellular domain (Cytogen 7E11 and Hybritech PM2). Fourteen patients with androgen-independent disease were treated with ATRA (50 mg/m2 p.o. every 8 h daily) and 16 androgen-independent and 4 androgen-dependent patients were treated with cRA inverted question markIFN (10 mg/kg/day cRA plus 3, 6, or 9 million units daily IFN). Both therapies were well tolerated, with fatigue and cheilitis being the most common adverse events. Clinical activity, assessed by radiographs and serum prostate-specific antigen, was minimal, and the majority of patients progressed within 3 months. One patient with androgen-dependent disease had prolonged stabilization for >1 year. The majority of cases (95%) showed no gross histological changes and no difference in apoptotic or proliferative indices. Increased PSMA immunoreactivity was seen in seven of nine (78%) cases using PM2 antibody and in two of nine (22%) cases using the 7E11 antibody. Although antitumor effects were modest, the results suggest a role for retinoids in modulating the expression of PSMA on prostate cancer cells.  (+info)

Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma. (6/437)

Although retinoids show promise for prevention of second primary upper aerodigestive tract tumors, the optimum retinoid, dose, and schedule are unknown. All-trans retinoic acid (ATRA) has greater affinity for retinoic acid receptors and may be more active than other retinoids but has a shorter plasma half life and may up-regulate its own metabolism. We defined the maximum long-term tolerable dose, dosing frequency, pharmacokinetics, and toxicity of ATRA in patients with treated squamous cell carcinoma of the head and neck (SCCHN). Twenty-one patients were randomized to 45, 90, or 150 mg/m2 ATRA either once daily, or as divided doses every 8 h, for 1 year. Pharmacokinetics were assessed periodically. Fourteen men and seven women with previous SCCHN of initial stage I-IV were treated. Grade > or =3 toxicities (reversible) included headache and hypertriglyceridemia in 5 and 6 patients each, mucositis in 2 patients, and hyperbilirubinemia, elevated alkaline phosphatase, colitis, lipasemia, xerostomia, eczema, and arthritis in 1 patient each. The 150-mg/m2 dose was not tolerable. Doses were reduced for grade > or =3 toxicity in seven of eight patients at 90 mg/m2 daily. Three of nine patients at 45 mg/m2/day required dose reduction, two at the once-daily dose. Day 1 ATRA area under the plasma concentration versus time curve (AUC) increased with dose, and after 1-2 months of continued dosing, the AUC declined in 7 of 13 patients (54%) studied. ATRA AUC did not correlate with toxicity severity or frequency. Fifteen mg/m2/day every 8 h is a tolerable dose for 1 year in patients with treated SCCHN. ATRA pharmacokinetics did not correlate with toxicity.  (+info)

Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir. (7/437)

Two patients complained of severe abdominal pain as the first sign of varicella zoster virus infection about 1 year after allogeneic BMT. In case 1, eruptions, found on the face and chest on admission, became vesicular and dispersed on the third hospital day. Though acyclovir (ACV) was immediately started, he died on the fourth day. In case 2, skin rash was never observed during the clinical course. Laparotomy on the third hospital day revealed many hemorrhagic spots on the liver surface and mucous membrane of the upper GI tract, indicating disseminated visceral disease. Empiric therapy with ACV was successful.  (+info)

Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. (8/437)

The recognition of the antibiotic sulfamethoxazole (SMX) by T cells is usually explained with the hapten-carrier model. However, recent investigations have revealed a MHC-restricted but processing- and metabolism-independent pathway of drug presentation. This suggested a labile, low-affinity binding of SMX to MHC-peptide complexes on APC. To study the role of covalent vs noncovalent drug presentation in SMX allergy, we analyzed the proliferative response of PBMC and T cell clones from patients with SMX allergy to SMX and its reactive oxidative metabolites SMX-hydroxylamine and nitroso-SMX. Although the great majority of T cell clones were specific for noncovalently bound SMX, PBMC and a small fraction of clones responded to nitroso-SMX-modified cells or were cross-reactive. Rapid down-regulation of TCR expression in T cell clones upon stimulation indicated a processing-independent activation irrespective of specificity for covalently or noncovalently presented Ag. In conclusion, our data show that recognition of SMX presented in covalent and noncovalent bound form is possible by the same TCR but that the former is the exception rather than the rule. The scarcity of cross-reactivity between covalently and noncovalently bound SMX suggests that the primary stimulation may be directed to the noncovalently bound SMX.  (+info)

An exanthem is a skin eruption or rash that often occurs as a symptom of various diseases, such as infectious illnesses. It can appear in different forms, including maculopapular (consisting of both macules and papules), vesicular (small fluid-filled blisters), petechial (small purple or red spots caused by bleeding under the skin), or erythematous (reddened). The rash can be localized to certain areas of the body or generalized, covering large parts or the entire body. Exanthems are usually accompanied by other symptoms related to the underlying disease, such as fever, cough, or muscle aches.

Exanthema subitum is a medical term that is used to describe a specific type of rash-like skin eruption. It's also known as roseola infantum or sixth disease, which is a common viral illness that typically affects young children between the ages of 6 months and 2 years.

The term "exanthema" refers to a widespread eruption of skin lesions, while "subitum" means sudden. Therefore, exanthema subitum can be defined as a sudden onset of a rash that is typically caused by the human herpesvirus 6 (HHV-6) infection.

The rash associated with exanthema subitum usually appears after the child has had a few days of high fever, which can sometimes reach up to 105°F (40.5°C). The rash is typically made up of small, flat or raised pink or red spots that may be surrounded by a lighter halo. These spots can appear anywhere on the body but are most commonly found on the trunk, neck, and face.

While the rash itself is generally not harmful, it can be uncomfortable for the child, causing itching or irritation. In most cases, exanthema subitum resolves on its own within a few days to a week without any specific treatment. However, if your child has a high fever, is lethargic, or shows other signs of illness, you should contact your healthcare provider for further evaluation and guidance.

Vesicular Exanthema of Swine (VES) is a viral disease that affects pigs, characterized by the formation of blisters or vesicles on the skin and mucous membranes. The causative agent is an RNA virus known as Vesicular Exanthema of Swine Virus (VESV), which belongs to the family Caliciviridae.

The disease is primarily transmitted through direct contact with infected pigs or contaminated fomites, and it can also be spread through the ingestion of contaminated food or water. The incubation period for VES ranges from 2-6 days, after which affected animals develop fever, lethargy, loss of appetite, and lameness.

The most notable clinical sign of VES is the development of vesicles on the snout, coronary bands, and hooves of infected pigs. These lesions can rupture and form crusts or scabs, leading to secondary bacterial infections. In severe cases, lameness can progress to the point where affected animals are unable to stand or walk.

VES is a highly contagious disease that can cause significant economic losses for pig farmers. While it does not pose a direct threat to human health, VESV can cause a mild self-limiting illness in humans who come into contact with infected pigs or their secretions.

It's worth noting that Vesicular Exanthema of Swine has been eradicated from the United States since 1952, and it is now considered a foreign animal disease. However, it remains a significant concern for the global swine industry due to its potential to cause significant economic losses.

Vesicular exanthema of swine (VES) is a viral disease that affects pigs, characterized by the formation of blisters or vesicles on the skin and mucous membranes. The causative agent of VES is a member of the Caliciviridae family, specifically the vesicular exanthema of swine virus (VESV).

The disease is highly contagious and can spread rapidly in pig populations through direct contact with infected animals or contaminated fomites. The incubation period for VES is typically 2-6 days, after which affected pigs may develop fever, lethargy, loss of appetite, and lameness. Within a few days, small fluid-filled vesicles appear on the snout, lips, ears, and coronary bands of the hooves. These vesicles can rupture, leading to the formation of raw, painful erosions that may become secondarily infected with bacteria.

While VES is not a direct threat to human health, it can cause significant economic losses in the swine industry due to decreased growth rates, reduced feed conversion, and increased mortality in affected animals. Additionally, the clinical signs of VES are similar to those of other vesicular diseases, such as foot-and-mouth disease (FMD), which can lead to costly trade restrictions and quarantines.

Historically, VES was a significant problem in the United States swine industry, but extensive vaccination programs and eradication efforts have largely eliminated the disease from domestic pig populations. However, VESV continues to circulate in wild pig populations and remains a potential threat to the swine industry.

Pinnipedia is not a medical term, but a taxonomic category in zoology. It refers to a group of marine mammals that include seals, sea lions, walruses, and related extinct species. These animals are characterized by their limbs being modified into flippers, which makes them well-adapted for life in the water. They are often studied in fields such as marine biology and veterinary medicine.

Human Herpesvirus 6 (HHV-6) is a species of the Roseolovirus genus in the Herpesviridae family. It is a double-stranded DNA virus and is one of the human herpesviruses, which are a group of viruses that includes eight different types that can infect humans.

There are two variants of HHV-6, known as HHV-6A and HHV-6B. Both variants are closely related but have distinct biological properties and clinical manifestations. HHV-6B is the cause of exanthem subitum (also known as roseola infantum or sixth disease), a common childhood illness characterized by fever and rash, while HHV-6A has been associated with various diseases in immunocompromised individuals, such as encephalitis, pneumonitis, and bone marrow suppression.

HHV-6 is highly prevalent in the human population, with most people getting infected during early childhood. After the initial infection, the virus remains latent in the body for the rest of a person's life, and it can reactivate under certain conditions, such as immune suppression or stress. Reactivation of HHV-6 has been associated with various diseases, including encephalitis, seizures, and fatigue.

It is important to note that while HHV-6 infection is common, most people do not develop any symptoms or long-term complications. However, in some cases, the virus can cause significant illness, especially in immunocompromised individuals.

Caliciviridae is a family of single-stranded, positive-sense RNA viruses that primarily infect animals, including humans. In humans, Caliciviridae causes gastroenteritis, commonly known as stomach flu, and is responsible for a significant portion of foodborne illnesses worldwide. The name "Caliciviridae" comes from the Latin word "calyx," meaning "cup," which refers to the cup-shaped depressions on the surface of some members of this virus family.

There are five genera within Caliciviridae that infect humans: Norovirus, Sapovirus, Lagovirus, Vesivirus, and Nebovirus. Among these, Norovirus is the most common cause of acute gastroenteritis in humans, accounting for approximately 90% of all cases.

Caliciviruses are small, non-enveloped viruses that range from 27 to 40 nanometers in diameter. They have a simple structure, consisting of a single protein shell (capsid) that encloses the RNA genome. The capsid proteins of Caliciviridae are organized into two major domains: the shell domain and the protruding domain. The protruding domain contains binding sites for host cell receptors and is responsible for eliciting an immune response in the host.

Caliciviruses are highly contagious and can be transmitted through various routes, including fecal-oral transmission, ingestion of contaminated food or water, and direct contact with infected individuals or surfaces. They are resistant to many common disinfectants and can survive for extended periods on environmental surfaces, making them difficult to eliminate from healthcare settings and other high-touch areas.

In addition to their medical importance, Caliciviridae also has significance in veterinary medicine, as several members of this family infect animals such as cats, dogs, pigs, and rabbits, causing a range of clinical symptoms from gastroenteritis to respiratory illnesses.

Herpesvirus 3, Equid (also known as Equine Herpesvirus 3 or EHV-3) is a species of herpesvirus that primarily affects horses and other equids. It belongs to the family Herpesviridae, subfamily Alphaherpesvirinae, and genus Varicellovirus.

EHV-3 is responsible for causing a disease called Equine Coital Exanthema (ECE), which is a venereal disease that affects the genitalia of horses. The virus is typically transmitted through sexual contact or during breeding, but it can also be spread through contaminated objects such as tack and equipment.

The symptoms of ECE include the development of small, fluid-filled blisters or lesions on the genitals, which may cause discomfort and lead to secondary infections. In most cases, the disease is self-limiting and resolves within a few weeks without treatment. However, it can have significant implications for breeding operations as it can result in temporary infertility in affected animals.

It's important to note that EHV-3 is not related to Human Herpesvirus 3 (Varicella-zoster virus), which causes chickenpox and shingles in humans.

Enteroviruses, Porcine are a group of viruses that belong to the family Picornaviridae and include several species that can infect pigs. These viruses are typically associated with respiratory and gastrointestinal illnesses in pigs, although some strains have been linked to reproductive problems and neurological disorders as well.

Some of the enteroviruses that can infect pigs include Porcine Enterovirus A (PEVA), Porcine Enterovirus B (PEVB), Porcine Enterovirus C (PEVC), Porcine Enterovirus D (PEVD), and Porcine Enterovirus E (PEVE). These viruses are usually spread through the fecal-oral route, and they can cause a range of clinical signs depending on the specific virus and the age and health status of the infected pig.

In general, porcine enteroviruses are not considered to be a significant threat to human health, although there have been rare reports of transmission from pigs to humans in cases where proper biosecurity measures were not followed. However, further research is needed to fully understand the potential risks associated with these viruses and their impact on both animal and human health.

I'm sorry for any confusion, but "Sea Lions" are not a medical term or condition. Sea lions are marine mammals belonging to the family Otariidae, which also includes fur seals. They are characterized by their external ear flaps, robust bodies, and strong foreflippers which they use for movement both in water and on land.

If you're looking for medical definitions or information, I'd be happy to help with that as well. Could you please clarify your question?

Drug hypersensitivity is an abnormal immune response to a medication or its metabolites. It is a type of adverse drug reaction that occurs in susceptible individuals, characterized by the activation of the immune system leading to inflammation and tissue damage. This reaction can range from mild symptoms such as skin rashes, hives, and itching to more severe reactions like anaphylaxis, which can be life-threatening.

Drug hypersensitivity reactions can be classified into two main types: immediate (or IgE-mediated) and delayed (or non-IgE-mediated). Immediate reactions occur within minutes to a few hours after taking the medication and are mediated by the release of histamine and other inflammatory mediators from mast cells and basophils. Delayed reactions, on the other hand, can take several days to develop and are caused by T-cell activation and subsequent cytokine release.

Common drugs that can cause hypersensitivity reactions include antibiotics (such as penicillins and sulfonamides), nonsteroidal anti-inflammatory drugs (NSAIDs), monoclonal antibodies, and chemotherapeutic agents. It is important to note that previous exposure to a medication does not always guarantee the development of hypersensitivity reactions, as they can also occur after the first administration in some cases.

The diagnosis of drug hypersensitivity involves a thorough medical history, physical examination, and sometimes skin or laboratory tests. Treatment typically includes avoiding the offending medication and managing symptoms with antihistamines, corticosteroids, or other medications as needed. In severe cases, emergency medical care may be required to treat anaphylaxis or other life-threatening reactions.

Human Herpesvirus 7 (HHV-7) is a species of the Herpesviridae family and Betaherpesvirinae subfamily. It is a double-stranded DNA virus that primarily infects human hosts. HHV-7 is closely related to Human Herpesvirus 6 (HHV-6) and both viruses share many biological and biochemical properties.

HHV-7 is typically acquired in early childhood, with most people becoming infected before the age of five. Primary infection with HHV-7 can cause a mild illness known as exanthema subitum or roseola infantum, which is characterized by fever and a rash. However, many HHV-7 infections are asymptomatic.

After initial infection, HHV-7 becomes latent in the host's immune cells, particularly CD4+ T-lymphocytes. The virus can reactivate later in life, causing various clinical manifestations such as chronic fatigue syndrome, seizures, and exacerbation of atopic dermatitis. HHV-7 has also been implicated in the development of certain malignancies, including lymphoproliferative disorders and some types of brain tumors.

Like other herpesviruses, HHV-7 establishes a lifelong infection in its human host, with periodic reactivation throughout the individual's lifetime.

A "drug eruption" is a general term used to describe an adverse skin reaction that occurs as a result of taking a medication. These reactions can vary in severity and appearance, and may include symptoms such as rash, hives, itching, redness, blistering, or peeling of the skin. In some cases, drug eruptions can also cause systemic symptoms such as fever, fatigue, or joint pain.

The exact mechanism by which drugs cause eruptions is not fully understood, but it is thought to involve an abnormal immune response to the medication. There are many different types of drug eruptions, including morphilliform rashes, urticaria (hives), fixed drug eruptions, and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), which is a severe and potentially life-threatening reaction.

If you suspect that you are experiencing a drug eruption, it is important to seek medical attention promptly. Your healthcare provider can help determine the cause of the reaction and recommend appropriate treatment. In some cases, it may be necessary to discontinue the medication causing the reaction and switch to an alternative therapy.

Promazine is a type of medication known as a phenothiazine antipsychotic. It works by blocking the action of dopamine, a neurotransmitter in the brain that is involved in emotion and thought. Promazine is primarily used to treat schizophrenia and other psychotic disorders, as well as to manage agitation and anxiety in certain medical conditions. It may also be used for its sedative effects in the management of insomnia or related sleep disturbances.

Promazine was first synthesized in the 1940s and has been used in clinical practice since then. It is available in various forms, including tablets and injectable solutions, and is typically administered two to four times a day. Common side effects of promazine include dry mouth, blurred vision, constipation, dizziness, and orthostatic hypotension (a sudden drop in blood pressure upon standing). Less commonly, it can cause extrapyramidal symptoms, such as tremors, rigidity, and akathisia (restlessness and inability to sit still).

It is important to note that promazine and other phenothiazine antipsychotics have been largely replaced by newer, atypical antipsychotic medications due to their greater efficacy and lower risk of extrapyramidal side effects. However, promazine may still be used in certain cases where its specific properties are desired or when other treatments have failed. As with any medication, it should only be used under the close supervision of a healthcare provider, who can monitor for potential adverse effects and adjust the dosage as needed.

Pityriasis rosea is a common, self-limited skin condition characterized by the development of oval or round, scaly, pinkish, inflamed patches on the skin. The initial lesion, known as the "herald patch," often appears before other lesions and measures 2-10 cm in diameter. It usually starts as a single, solitary, scaly, raised patch on the trunk that precedes the generalized eruption by about 1-2 weeks. The rash typically spreads to involve the chest, abdomen, back, arms, and legs, sparing the face, palms, and soles.

The rash is often asymptomatic but can be pruritic (itchy) in some cases. It usually resolves within 6-12 weeks without any treatment, although topical treatments such as corticosteroids or antihistamines may be used to relieve itching. The exact cause of pityriasis rosea is not known, but it is thought to be caused by a viral infection. It is more common in young adults and is more prevalent in the spring and fall seasons.

The uvula is a small, conical piece of soft tissue that hangs down from the middle part of the back of the soft palate (the rear-most portion of the roof of the mouth). It contains muscle fibers and mucous glands, and its function is associated with swallowing, speaking, and protecting the airway. During swallowing, the uvula helps to prevent food and liquids from entering the nasal cavity by blocking the opening between the oral and nasal cavities (the nasopharynx). In speech, it plays a role in shaping certain sounds like "a" and "u."

Quinolizines are not a medical term, but a chemical classification for a group of compounds that contain a quinolizine ring in their structure. A quinolizine ring is a polycyclic aromatic hydrocarbon with eight pi electrons and consists of two benzene rings fused to a piperidine ring.

Quinolizines have been studied for their potential medicinal properties, including anti-malarial, anti-cancer, and anti-microbial activities. However, there are no currently approved drugs that contain quinolizine as the primary active ingredient. Therefore, it is not possible to provide a medical definition of 'Quinolizines.'

Roseolovirus infections are typically caused by human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7). The most common manifestation of roseolovirus infection is exanthem subitum, also known as roseola infantum or sixth disease, which primarily affects children aged 6 months to 2 years.

The infection usually begins with a fever that can last for up to a week, followed by the appearance of a rash once the fever subsides. The rash is typically pinkish-red, maculopapular (consisting of both flat and raised lesions), and appears on the trunk, spreading to the face, neck, and extremities. It usually lasts for 1-2 days.

In addition to exanthem subitum, roseolovirus infections can also cause a variety of other clinical manifestations, including febrile seizures, hepatitis, pneumonitis, myocarditis, and encephalitis. HHV-6 and HHV-7 have also been associated with several chronic diseases, such as chronic fatigue syndrome, multiple sclerosis, and certain malignancies.

Transmission of roseolovirus occurs through saliva and other bodily fluids, and primary infection is usually acquired during childhood. Once infected, the virus remains latent in the body and can reactivate later in life, although reactivation rarely causes symptoms.

Vitamin K1, also known as phylloquinone, is a type of fat-soluble vitamin K. It is the primary form of Vitamin K found in plants, particularly in green leafy vegetables such as kale, spinach, and collard greens. Vitamin K1 plays a crucial role in blood clotting and helps to prevent excessive bleeding by assisting in the production of several proteins involved in this process. It is also essential for maintaining healthy bones by aiding in the regulation of calcium deposition in bone tissue. A deficiency in Vitamin K1 can lead to bleeding disorders and, in some cases, osteoporosis.

Stevens-Johnson Syndrome (SJS) is a rare, serious and potentially life-threatening skin reaction that usually occurs as a reaction to medication but can also be caused by an infection. SJS is characterized by the detachment of the epidermis (top layer of the skin) from the dermis (the layer underneath). It primarily affects the mucous membranes, such as those lining the eyes, mouth, throat, and genitals, causing painful raw areas that are prone to infection.

SJS is considered a severe form of erythema multiforme (EM), another skin condition, but it's much more serious and can be fatal. The symptoms of SJS include flu-like symptoms such as fever, sore throat, and fatigue, followed by a red or purplish rash that spreads and blisters, eventually leading to the detachment of the top layer of skin.

The exact cause of Stevens-Johnson Syndrome is not always known, but it's often triggered by medications such as antibiotics, anti-convulsants, nonsteroidal anti-inflammatory drugs (NSAIDs), and antiretroviral drugs. Infections caused by herpes simplex virus or Mycoplasma pneumoniae can also trigger SJS.

Treatment for Stevens-Johnson Syndrome typically involves hospitalization, supportive care, wound care, and medication to manage pain and prevent infection. Discontinuing the offending medication is crucial in managing this condition. In severe cases, patients may require treatment in a burn unit or intensive care unit.

Herpesviridae infections refer to diseases caused by the Herpesviridae family of double-stranded DNA viruses, which include herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), varicella-zoster virus (VZV), cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8). These viruses can cause a variety of clinical manifestations, ranging from mild skin lesions to severe systemic diseases.

After the initial infection, these viruses typically become latent in various tissues and may reactivate later in life, causing recurrent symptoms. The clinical presentation of Herpesviridae infections depends on the specific virus and the immune status of the host. Common manifestations include oral or genital ulcers (HSV-1 and HSV-2), chickenpox and shingles (VZV), mononucleosis (CMV), roseola (HHV-6), and Kaposi's sarcoma (HHV-8).

Preventive measures include avoiding close contact with infected individuals during the active phase of the infection, practicing safe sex, and avoiding sharing personal items that may come into contact with infectious lesions. Antiviral medications are available to treat Herpesviridae infections and reduce the severity and duration of symptoms.

Minocycline is an antibiotic medication that belongs to the tetracycline class. Medically, it is defined as a semisynthetic derivative of tetracycline and has a broader spectrum of activity compared to other tetracyclines. It is bacteriostatic, meaning it inhibits bacterial growth rather than killing them outright.

Minocycline is commonly used to treat various infections caused by susceptible bacteria, including acne, respiratory infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted diseases. Additionally, it has been found to have anti-inflammatory properties and is being investigated for its potential use in treating neurological disorders such as multiple sclerosis and Alzheimer's disease.

As with all antibiotics, minocycline should be taken under the guidance of a healthcare professional, and its usage should be based on the results of bacterial culture and sensitivity testing to ensure its effectiveness against the specific bacteria causing the infection.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

Antibiotic prophylaxis refers to the use of antibiotics to prevent infection from occurring in the first place, rather than treating an existing infection. This practice is commonly used before certain medical procedures or surgeries that have a high risk of infection, such as joint replacements, heart valve surgery, or organ transplants. The goal of antibiotic prophylaxis is to reduce the risk of infection by introducing antibiotics into the body before bacteria have a chance to multiply and cause an infection.

The choice of antibiotic for prophylaxis depends on several factors, including the type of procedure being performed, the patient's medical history and allergies, and the most common types of bacteria that can cause infection in that particular situation. The antibiotic is typically given within one hour before the start of the procedure, and may be continued for up to 24 hours afterward, depending on the specific guidelines for that procedure.

It's important to note that antibiotic prophylaxis should only be used when it is truly necessary, as overuse of antibiotics can contribute to the development of antibiotic-resistant bacteria. Therefore, the decision to use antibiotic prophylaxis should be made carefully and in consultation with a healthcare provider.

Metronidazole is an antibiotic and antiprotozoal medication. It is primarily used to treat infections caused by anaerobic bacteria and certain parasites. Metronidazole works by interfering with the DNA of these organisms, which inhibits their ability to grow and multiply.

It is available in various forms, including tablets, capsules, creams, and gels, and is often used to treat conditions such as bacterial vaginosis, pelvic inflammatory disease, amebiasis, giardiasis, and pseudomembranous colitis.

Like all antibiotics, metronidazole should be taken only under the direction of a healthcare provider, as misuse can lead to antibiotic resistance and other complications.

Topical administration refers to a route of administering a medication or treatment directly to a specific area of the body, such as the skin, mucous membranes, or eyes. This method allows the drug to be applied directly to the site where it is needed, which can increase its effectiveness and reduce potential side effects compared to systemic administration (taking the medication by mouth or injecting it into a vein or muscle).

Topical medications come in various forms, including creams, ointments, gels, lotions, solutions, sprays, and patches. They may be used to treat localized conditions such as skin infections, rashes, inflammation, or pain, or to deliver medication to the eyes or mucous membranes for local or systemic effects.

When applying topical medications, it is important to follow the instructions carefully to ensure proper absorption and avoid irritation or other adverse reactions. This may include cleaning the area before application, covering the treated area with a dressing, or avoiding exposure to sunlight or water after application, depending on the specific medication and its intended use.

Gastrointestinal (GI) neoplasms refer to abnormal growths in the gastrointestinal tract, which can be benign or malignant. The gastrointestinal tract includes the mouth, esophagus, stomach, small intestine, large intestine, rectum, and anus.

Benign neoplasms are non-cancerous growths that do not invade nearby tissues or spread to other parts of the body. They can sometimes be removed completely and may not cause any further health problems.

Malignant neoplasms, on the other hand, are cancerous growths that can invade nearby tissues and organs and spread to other parts of the body through the bloodstream or lymphatic system. These types of neoplasms can be life-threatening if not diagnosed and treated promptly.

GI neoplasms can cause various symptoms, including abdominal pain, bloating, changes in bowel habits, nausea, vomiting, weight loss, and anemia. The specific symptoms may depend on the location and size of the neoplasm.

There are many types of GI neoplasms, including adenocarcinomas, gastrointestinal stromal tumors (GISTs), lymphomas, and neuroendocrine tumors. The diagnosis of GI neoplasms typically involves a combination of medical history, physical examination, imaging studies, and biopsy. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or immunotherapy.

Prednisolone is a synthetic glucocorticoid drug, which is a class of steroid hormones. It is commonly used in the treatment of various inflammatory and autoimmune conditions due to its potent anti-inflammatory and immunosuppressive effects. Prednisolone works by binding to specific receptors in cells, leading to changes in gene expression that reduce the production of substances involved in inflammation, such as cytokines and prostaglandins.

Prednisolone is available in various forms, including tablets, syrups, and injectable solutions. It can be used to treat a wide range of medical conditions, including asthma, rheumatoid arthritis, inflammatory bowel disease, allergies, skin conditions, and certain types of cancer.

Like other steroid medications, prednisolone can have significant side effects if used in high doses or for long periods of time. These may include weight gain, mood changes, increased risk of infections, osteoporosis, diabetes, and adrenal suppression. As a result, the use of prednisolone should be closely monitored by a healthcare professional to ensure that its benefits outweigh its risks.

Detergents are cleaning agents that are often used to remove dirt, grease, and stains from various surfaces. They contain one or more surfactants, which are compounds that lower the surface tension between two substances, such as water and oil, allowing them to mix more easily. This makes it possible for detergents to lift and suspend dirt particles in water so they can be rinsed away.

Detergents may also contain other ingredients, such as builders, which help to enhance the cleaning power of the surfactants by softening hard water or removing mineral deposits. Some detergents may also include fragrances, colorants, and other additives to improve their appearance or performance.

In a medical context, detergents are sometimes used as disinfectants or antiseptics, as they can help to kill bacteria, viruses, and other microorganisms on surfaces. However, it is important to note that not all detergents are effective against all types of microorganisms, and some may even be toxic or harmful if used improperly.

It is always important to follow the manufacturer's instructions when using any cleaning product, including detergents, to ensure that they are used safely and effectively.

"Swine" is a common term used to refer to even-toed ungulates of the family Suidae, including domestic pigs and wild boars. However, in a medical context, "swine" often appears in the phrase "swine flu," which is a strain of influenza virus that typically infects pigs but can also cause illness in humans. The 2009 H1N1 pandemic was caused by a new strain of swine-origin influenza A virus, which was commonly referred to as "swine flu." It's important to note that this virus is not transmitted through eating cooked pork products; it spreads from person to person, mainly through respiratory droplets produced when an infected person coughs or sneezes.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

No FAQ available that match "exanthema"

No images available that match "exanthema"